Great innovators. Look for good things from them in 2009.

This has a lupus drug in Phase 3. There have been virtually NO developements for the treatment of lupus. Patients are left with few treatments, and the drugs that do help have horrendous side effects. Plaquenil causes macular degeneration which leads to blindness. Prednisone leads to huge weight gain and diabetes and its attendent illnesses. NSAIDs lead to stomach ailments, etc. When the lupus drug is finished, it will be a blockbuster drug and a major scientific breakthrough.

Neighbor recommended it to me. Has been very good to me so far!

Sodium Ion Channel Blocking medication underway to help develop a new drug for pain relief. Pain is a huge problem that costs American businesses tons of money. Backed by Pfizer.

Solid company with good divy.

Speculative natural gas play has brought me a 27% increase so far. Has a deal with state of NJ for an offshore nat gas pipeline. Own it with confidence.

Great patented nanoparticle technology for wound closure that will save money and boost productivity in hospitals. Though a penny stock, has some major institutional investors. Just added Mr. Ronald Ahrens to be the director of company, age 67. Mr. Ahrens has background with Merck, Bristol-Myers Squibb, Richardson Vicks, and Proctor&Gamble. 10.97% stake bought in it by Rocye & Associates this week (7/8/08).

Investment for future.